Biohit Oyj's Diagnostic Starts Large China Gastric Cancer Screening Study

A giant gastric cancer screening study, which will test at least 20,000 people in 50 hospitals, has started in China, using the GastroPanel test developed by Finland's Biohit Oyj. The goal is early detection of gastric cancer, a prevalent form of cancer in China. One year ago, Biohit Oyj formed a JV with Anhui Wisdom-Win Investment Co. to make and distribute the GastroPanel in China. More details.... Stock Symbol: (HEL: BIOBV) Share this with colleagues: // //